Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by partystockeron Oct 04, 2022 5:16pm

AGN.c seems to be running an efficient business.

There is nothing more important for a new company than a capital efficient business model, and Algernon Pharmaceuticals (CSE: AGN) is a great example of this.  To date, AGN has received over ...more  
140
Post by Justdosomeddon Oct 04, 2022 3:34pm

DMT to IPF, Promising Continued Research

Drug repurposing allows companies to fully utilize existing pharmaceutical knowledge and leverage it for novel purposes. Repurposing is also far more advantageous when it comes to trials, testing, and ...more  
73
Post by stockpatrolon Oct 03, 2022 5:57pm

AGN.c begun phase 1 study of their groundbreaking DMT treatm

AGN.c begun phase 1 study of their groundbreaking DMT treatment for post-stroke recovery    https://twitter.com/Psych_Fin/status/1577032702175629313   AGN.c will be the headline ...more  
94
Post by Nice1Buckoon Oct 03, 2022 3:51pm

AGN AGN.CA 🍄🍄🍄

Algernon are becoming a leader in the microdose psychedelic pharmaceutical space
52
Post by bmreedon Oct 03, 2022 12:16pm

Video Recap - $AGN CEO Christopher Moreau & Radius Research

Webinar Recap: Algernon Pharmaceuticals (AGN) w CEO Chris Moreau - Pitch, Deep Dive and Q&A - https://youtu.be/KXzh3-86szc   CEO Chris Moreau discusses recent developments, including ...more  
88
Post by stockpatrolon Sep 30, 2022 6:28pm

AGN.c receives approval to conduct DMT study in the Netherla

AGN.c receives approval to conduct DMT study in the Netherlands.    https://twitter.com/big_gonads/status/1575896549456220160   Phase 1 of this study will examine intravenous ...more  
132
Post by biggonadson Sep 30, 2022 2:10pm

AGN gains approval to conduct DMT trials in Netherlands

While Algernon eyes one of the most significant catalysts possible for any biotech stock with its orphan designation with the FDA pending for its use of Ifenprodil, they are also advancing their other ...more  
116
Post by partystockeron Sep 29, 2022 3:03pm

AGN.c receives additional $450K tax credit.

Algernon Pharmaceuticals (CSE: AGN) has announced the receipt of a $450K cash refund from its Australian research program. This latest installment brings the company’s total tax refunds to over $3M ...more  
75
Post by Justdosomeddon Sep 29, 2022 2:48pm

Continued Progress With Their Research

Drug development is often lengthy, dangerous, and extremely expensive alongside the unknown results that will occur. $AGN.C is a company focusing on drug development with a rather different approach ...more  
71
Post by partystockeron Sep 28, 2022 3:47pm

AGN.c files for Orphan Drug Designation.

Algernon Pharmaceuticals (CSE: AGN) recently made a big step in the advancement of its IPF treatment, Ifenprodil. On September 19, the company filed a request for Orphan Drug Designation with the USDA ...more  
84
Post by Nice1Buckoon Sep 28, 2022 2:09pm

AGN AGN.CA 💊💊👨🏻‍⚕️👨🏻‍⚕️

DMT for treatment of stroke? https://algernonpharmaceuticals.com/proactive-investors-interview-algernon-pharmaceuticals-gains-approval-for-phase-1-clinical-study-of-dmt-for-treatment-of-stroke/
61
Post by culturedpiggy01on Sep 26, 2022 6:03pm

AGN.c | Company webinar w/ CEO Chris Moreau

AGN.c is holding a webinar including a Q&A with CEO Chris Moreau. Def would recommend going, Moreau will talk about funding, recent positive study result and more. You can register here https ...more  
97
Post by bmreedon Sep 26, 2022 5:54pm

Tomorrow - Webinar w Algernon Pharma $AGN CEO Chris Moreau

Webinar - Algernon Pharmaceuticals $AGN w/ CEO Chris Moreau Tue, September 27 at 12:30pm ET / 9:30am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar ...more  
102
Post by SkywalkerofLukeon Sep 23, 2022 12:50pm

Recent News

A little surprised with AGN.c (a clinical stage Canadian pharmaceutical development company) AGNPF ‘s action as of late considering their recent news. Especially the announcement that they filed a ...more  
159
Post by bmreedon Sep 22, 2022 6:56pm

Webinar w $AGN CEO Chris Moreau - Tue Sep 27 @ 12:30PM ET

Webinar - Algernon Pharmaceuticals $AGN w/ CEO Chris Moreau Tue, September 27 at 12:30pm ET / 9:30am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar ...more  
95
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next